Under the agreement, Garmin will combine its wearables with ActiGraph‘s CentrePoint data analytics platform to carry out academic research, clinical trials and remote patient monitoring.
CentrePoint uses customised analytics, cloud and mobile technologies to provide physical activity and sleep metrics along with real-time visibility of subjects, research sites and overall study progress.
ActiGraph portfolio also includes wearable accelerometry monitors designed for objective, physical activity measurement. They have been adopted by more than 1,500 pharmaceutical, academic and scientific institutions.
Garmin Health global product lead Travis Johnson said: “Garmin Health is excited to work with a globally recognised company like ActiGraph that shares an engineering commitment to pioneer high-quality solutions that can be trusted by the scientific community and pharmaceutical market.
“Combining the sensor data from Garmin wearables with the data capture and analytical expertise of the ActiGraph platform creates a powerful solution for many different patient monitoring applications.”
Garmin focuses on the creation of wearables for the detection of serious health conditions and the development of conventional and digital therapeutics.
The latest partnership is intended to speed up these developments to improve health outcomes.
ActiGraph chief technology officer and product development senior vice-president Jeremy Wyatt said: “Garmin wearables produce high-resolution, accurate data streams that are ideal for scientific analysis and can provide additional, novel endpoints to the ActiGraph software platform.
“What’s more, the long battery life and ergonomic design of Garmin’s wearables means study participants can comfortably wear the devices for extended periods, leading to improved programme adherence and study results.”